Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Oneview Healthcare (ASX:ONE) Stock Under Pressure: What Investors Should Know

Oneview Healthcare Plc (ASX:ONE) shares traded at $0.12, down 14.29%, during theTrading sessionon 26 October 2026, while the S&P/ASX 200index(XJO) stood at 8,805.30, up 0.11% or 10.10 points, at 2:06 pm. Separately, the company's latest announcement on file is dated 6-month period ended 30 …

Sonal Goyal | 26 October 2026

ASX Healthcare Stocks Under Pressure: Oneview, Adheris Health and Little Green Pharma

Oneview Healthcare (ASX:ONE) at $0.12, down 14.29%, Adheris Health (ASX:AHE) at $0.013, down 13.33% and Little Green Pharma (ASX:LGP) at $0.059, down 9.23% were among the ASX decliners during theTrading sessionon 26 October 2026, while the S&P/ASX 200index(XJO) stood at 8,805.30, up 0.11% or …

Sonal Goyal | 26 October 2026

Argent Biopharma (ASX:RGT) Stock Lower: What's Behind the Move?

Argent Biopharma Ltd (ASX:RGT) shares traded at $0.029, down 9.38%, during theTrading sessionon 26 October 2026, while the S&P/ASX 200index(XJO) stood at 8,805.30, up 0.11% or 10.10 points, at 2:06 pm. Separately, the company's latest announcement on file is dated 23 October 2026 and …

Sonal Goyal | 26 October 2026

Why INOVIQ (ASX:IIQ) chief executive Dr Leearne Hinch will step down on 27 October as the chair moves into an interim executive role

INOVIQ Ltd (ASX:IIQ) announced on 23 October 2026 that Dr Leearne Hinch will step down as chief executive officer on 27 October 2026. The company said the change was mutually agreed between the board and Dr Hinch. Chairman Peter Gunzburg will become executive chair …

Sonal Goyal | 23 October 2026

Why Paradigm Biopharmaceuticals (ASX:PAR) Administrators Are Seeking a Court Extension and Have Redeemed Further Convertible Notes

The voluntary administrators of Paradigm Biopharmaceuticals Limited (ASX:PAR) (Administrators Appointed) have applied to the Supreme Court of Western Australia to extend the convening period for the second meeting of creditors by up to three months. Separately, the company has paid US$348,900.38 to redeem a …

Sonal Goyal | 23 October 2026

Why Proteomics International (ASX:PIQ) Is Taking Its PromarkerD and PromarkerEso Diagnostic Tests National Through Healius

Proteomics International Laboratories (ASX:PIQ) has announced the national rollout of two of its Promarker diagnostic tests, PromarkerD and PromarkerEso, through its exclusive Australian pathology distribution partner, Healius Limited (ASX:HLS). The company said the rollout and supporting systems are scheduled to go live on Monday …

Sonal Goyal | 23 October 2026

Why Argent BioPharma (ASX:RGT) Reported $11,000 of Cash at 30 September 2026 and A$3.6 Million Drawn on Its Convertible Note Facility

Argent BioPharma (ASX:RGT) has released its Appendix 4C and quarterly activities report for the three months to 30 September 2026. The reported figures are a net operating cash outflow of A$734,000 and closing cash of A$11,000, with A$600,000 drawn from convertibleDebtsecurities. The company also …

Sonal Goyal | 23 October 2026

Why Arovella Therapeutics (ASX:ALA) Expects First Patient Dosing in Its CAR-iNKT Lymphoma Trial in October 2026

Arovella Therapeutics Limited (ASX:ALA) said in its quarterly update for the period ended 30 September 2026 that its focus is ALA-101, a CD19-targeted CAR-iNKT cell therapy for blood cancers. The company said two manufacturing batches were manufactured and released for clinical use in September …

Sonal Goyal | 23 October 2026

Why Amplia Therapeutics (ASX:ATX) Has Received a A$4.78 Million R&D Tax Incentive Rebate for Its Pancreatic Cancer Programme

Amplia Therapeutics Limited (ASX:ATX) has received A$4,778,235.52 from the Australian Taxation Office under theResearch and DevelopmentTax Incentive, covering the financial year ended 31 March 2026. The company announced the receipt on 22 October 2026.

Sonal Goyal | 23 October 2026

Why Doctor Care Anywhere (ASX:DOC) Has Published a UK Virtual Healthcare Strategy Update Centred on Weight Management and Subscriptions

Doctor Care Anywhere Group (ASX:DOC), a UK company with CDIs on the ASX, published a Strategy and Business Model Update and a short-form investor primer on 23 October 2026 (Sydney time). The documents contain no forecasts, targets or new results. They restate the company's …

Sonal Goyal | 23 October 2026
Support

Hi! How can we help you today?

Loading…